Norliqva Solution
Product Images NDC 46287-037

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Norliqva (NDC 46287-037). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cmp Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Norliquid 01)

Chemical structure diagram of amlodipine showing its molecular bonds and constituent groups, including chlorine, methyl, ethyl, sulfonate, and amino components, consistent with the active ingredient in NORLIQVA oral solution.*

FDA Label Image

Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)

A line graph comparing event rates over time (months) between 'Placebo' and 'Amlodipine' groups. The x-axis shows time in months up to 24, and the y-axis shows event rate from 0 to 0.25. The graph includes a statistical inset with P-value 0.003, hazard ratio 0.691, and 95% confidence interval (0.54, 0.88). The event rate for placebo is higher than for amlodipine throughout the timeline.*

FDA Label Image

Figure 2 – Effects On Primary Endpoint Of Amlodipine Versus Placebo Across Sub-groups (Norliquid 03)

A forest plot chart illustrating hazard ratios with 95% confidence intervals comparing amlodipine versus placebo across different patient subgroups including overall, age, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent status. The x-axis represents hazard ratios ranging from 0.0 to 2.0, with a vertical line at 1.0 indicating no difference between treatments.*

FDA Label Image

Principal Display Panel (150 mL Bottle Label)

The label for Norliqva (amlodipine) oral solution features a 1 mg/mL strength in a 150 mL bottle. It is alcohol-free and for oral use only. The label includes storage instructions, a barcode, distributor information (CMP Pharma, Inc.), and note that the product is made in India. The NDC is 46287-037-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.